Table 3
Open in new tab

Trastuzumab treatment of the whole Hermine cohort

aPatients could have received more than drug in combination with trastuzumab during the minimum follow-up of 2 years.

Table 3
Open in new tab

Trastuzumab treatment of the whole Hermine cohort

aPatients could have received more than drug in combination with trastuzumab during the minimum follow-up of 2 years.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close